Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

Publikation: Bidrag til tidsskriftLetterfagfællebedømt

Standard

Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab. / Chodziuk, Astrid C.; Ghazanfar, Misbah N.; Thomsen, Simon F.

I: Dermatologic Therapy, Bind 32, Nr. 3, e12902, 2019.

Publikation: Bidrag til tidsskriftLetterfagfællebedømt

Harvard

Chodziuk, AC, Ghazanfar, MN & Thomsen, SF 2019, 'Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab', Dermatologic Therapy, bind 32, nr. 3, e12902. https://doi.org/10.1111/dth.12902

APA

Chodziuk, A. C., Ghazanfar, M. N., & Thomsen, S. F. (2019). Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab. Dermatologic Therapy, 32(3), [ e12902]. https://doi.org/10.1111/dth.12902

Vancouver

Chodziuk AC, Ghazanfar MN, Thomsen SF. Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab. Dermatologic Therapy. 2019;32(3). e12902. https://doi.org/10.1111/dth.12902

Author

Chodziuk, Astrid C. ; Ghazanfar, Misbah N. ; Thomsen, Simon F. / Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab. I: Dermatologic Therapy. 2019 ; Bind 32, Nr. 3.

Bibtex

@article{49d9fbd679644ac5bb4d5d6f84eed85b,
title = "Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab",
author = "Chodziuk, {Astrid C.} and Ghazanfar, {Misbah N.} and Thomsen, {Simon F.}",
year = "2019",
doi = "10.1111/dth.12902",
language = "English",
volume = "32",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

AU - Chodziuk, Astrid C.

AU - Ghazanfar, Misbah N.

AU - Thomsen, Simon F.

PY - 2019

Y1 - 2019

U2 - 10.1111/dth.12902

DO - 10.1111/dth.12902

M3 - Letter

C2 - 30964569

VL - 32

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 3

M1 - e12902

ER -

ID: 226113285